Funding approved for Avelumab in combination with Axitinib

  KCSN are formal consultees to N I C E and part of the process that appraises all new kidney cancer drugs.  We are delighted to tell you that, as from today, kidney cancer patients can get NHS funding via the Cancer Drugs Fund for Avelumab in combination with Axitinib as a 1st line treatment for […]

read more

Encouraging results from two COVID-19 vaccine trials

Encouraging results have been published for two phase 1/2 COVID-19 vaccine trials, one from the University of Oxford with support from Astra Zeneca, the other from researchers supported by CanSino Biologics in Wuhan, China. Both groups used a virus vector, and both report responses of the vaccine to SARS-CoV-2 by day 28 as well as […]

read more

Delay in cancer diagnosis during COVID-19 – what next?

This article in The Lancet describes the impact of the COVID-19 pandemic on the two-week wait referral for cancer diagnosis in the UK from the results of two modelling studies looking at up to 20 different cancers. The article concludes that patients whose symptoms indicate cancer have been disadvantaged, and some patients will die as […]

read more

Combination of potential biomarkers may help predict response to immunotherapy in kidney cancer

Currently, it is difficult for clinicians to decide which patients will respond to immunotherapy and, therefore, what is the best course of treatment for patients with metastatic renal cell carcinoma (RCC). A recent study published in Oncoimmunology describes a combination of two potential biomarkers that may help predict response to immunotherapy for metastatic RCC patients, […]

read more

Study shows steep rise in people waiting for cancer tests

The results from two studies have been released to show the impact of the COVID-19 pandemic on cancer care in the UK. Data from Cancer Research UK showed a steep rise in the number of people waiting for diagnostic tests, while a study by the Institute for Cancer Research (ICR) published in The Lancet warned that […]

read more

Impact of COVID-19 on the treatment of metastatic kidney cancer

Because so little was known about coronavirus at the start of the pandemic, there was a lot of discussion between healthcare professionals about the best way to manage cancer patients with the threat of infection with the virus. In recent years, immune checkpoint inhibitors have become standard of care for most metastatic renal cell carcinoma […]

read more
Showing 1 to 6 of 906 results